HR Execs on the Move

Stemedica

www.stemedica.com

 
Stemedica Cell Technologies, Inc., a biopharmaceutical company, engages in the development and manufacture of adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies. The company was incorporated in 2005 and is based in San Diego, California with a subsidiary location in Lausanne, Switzerland.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.stemedica.com
  • 5375 Mira Sorrento Pl Ste 100
    San Diego, CA USA 92121-3804
  • Phone: 858.658.0910

Executives

Name Title Contact Details

Similar Companies

RX for Brown Skin Care

RX for Brown Skin Care is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Simply Smiles

Simply Smiles is a Westport, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WithMe Health

WithMe Health replaces an employer`s pharmacy benefit manager (PBM) with a personalized medication guidance solution that greatly improves on and expands the scope of services available in the market today. Our modern technology and rich datasets allow consistent application of proven science to create individualized medication experiences for employees and their families that are proactive, adaptive, convenient and engaging. With an innovative, outcomes-oriented business model that aligns interests across the pharmaceutical value chain, WithMe Health optimizes health outcomes and value while substantially reducing costs for employers.

Tri-State Clinical Laboratory Services

Tri-State Clinical Laboratory Services, LLC is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Aratana Terapeutics

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.